Split History
ETFs Holding CNDO »    CNDO Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Coronado Biosciences is a biopharmaceutical company focused on the development of immunotherapy biologic agents for the treatment of autoimmune diseases and cancer. Co.'s two principal product candidates in clinical development are: CNDO-201, or Trichuris suis ova, a biologic comprising the microscopic eggs of the porcine whipworm, for the treatment of autoimmune diseases, such as Crohn's disease, ulcerative colitis, multiple sclerosis, autism, psoriasis, and type one diabetes; and CNDO-109, a biologic that activates the immune system's natural killer cells to seek and destroy cancer cells, for the treatment of acute myeloid leukemia. According to our CNDO split history records, CNDO has had 1 split.
CNDO split history picture
CNDO (CNDO) has 1 split in our CNDO split history database. The split for CNDO took place on February 21, 2006. This was a 1 for 10 reverse split, meaning for each 10 shares of CNDO owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split.

When a company such as CNDO conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the CNDO split history from start to finish, an original position size of 1000 shares would have turned into 100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into CNDO shares, starting with a $10,000 purchase of CNDO, presented on a split-history-adjusted basis factoring in the complete CNDO split history. CNDO split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 11/17/2011
End date: 04/27/2015
Start price/share: $11.00
End price/share: $3.44
Dividends collected/share: $0.00
Total return: -68.73%
Average Annual Total Return: -28.67%
Starting investment: $10,000.00
Ending investment: $3,126.77
Years: 3.44
Date Ratio
02/21/20061 for 10
CNDO is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

CNMD Split History
COO Split History
COV Split History
CRDC Split History
CRIS Split History
CRMD Split History
CRTX Split History
CRVL Split History
CRY Split History
CSBR Split History

LM Funding America, Inc. (LMFA)
Foxby Corp. (XFXBX)
InspireMD, Inc. (NSPR)
Aviat Networks, Inc. (AVNW)
Guardion Health Sciences, Inc. (GHSI)
China SXT Pharmaceuticals, Inc. (SXTC)
VYNE Therapeutics Inc. (VYNE)
The Sherwin-Williams Company (SHW)
Horizons US Marijuana Index ETF (HMUS)
MicroSectors FANG+ ETNs due January 8, 2038 (FNGS)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

CNDO Insider Buying

CNDO Split History | www.SplitHistory.com | Copyright © 2013 - 2021, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.